glp-1 drug updates Medicare is about to cover drugs for weight loss. Here's what to know The promises and pitfalls of
Description
Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) is a 39-amino acid triple-receptor peptide
In obese mice, Tirzepatide interventions have been shown to enhance -cell proliferation and function, reduce glucotoxicity, and extend life expectancy
doi: 10.1038/s41598-024-57724-5
Users are warned about thyroid cancer, pancreatitis, kidney problems, gallbladder disease, and allergic reactions
